Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “cells”

914 pharma patents match "cells" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 914
Index total 30,257
Page 23 / 39

Quick answer

This filtered view shows 914 pharmaceutical patents matching "cells" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

914 results for “cells” · 30,257 patents in full index Clear search

  1. US 9492538

    Isolation and use of solid tumor stem cells

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Nov 15, 2016 · Expires Nov 10, 2036

    granted

  2. US 9493833

    Methods for preventing induced synthesis of proteasomes in human cells

    The Regents of the University of California · Granted Nov 15, 2016 · Expires Nov 10, 2036

    granted

  3. US 9491934

    Regulation of endogenous gene expression in cells using zinc finger proteins

    Sangamo Biosciences, Inc. · Granted Nov 15, 2016 · Expires Nov 10, 2036

    granted

  4. US 9487753

    Compositions of adult disc stem cells and methods for the treatment of degenerative disc disease

    DiscGenics, Inc. · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted

  5. US 9487556

    Polyconjugates for delivery of RNAi triggers to tumor cells in vivo

    Arrowhead Pharmaceuticals, Inc. · Granted Nov 8, 2016 · Expires Nov 3, 2036

    granted

  6. US 9481866

    Methods of producing T cell populations enriched for stable regulatory T-cells

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 1, 2016 · Expires Oct 27, 2036

    granted

  7. US 9474787

    Mesenchymal stem cells for the treatment of CNS diseases

    BRAINSTORM CELL THERAPEUTICS LTD. · Granted Oct 25, 2016 · Expires Oct 20, 2036

    granted

  8. US 9468632

    Methods and compositions for targeting cancer stem cells

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Oct 18, 2016 · Expires Oct 13, 2036

    granted

  9. US 9428731

    Technologies, methods, and products of small molecule directed tissue and organ regeneration from human pluripotent stem cells

    San Diego Regenerative Medicine Institute · Granted Aug 30, 2016 · Expires Aug 25, 2036

    granted

  10. US 9422522

    Method of producing adipocytes from fibroblast cells

    Regenertech Pty Limited · Granted Aug 23, 2016 · Expires Aug 18, 2036

    granted

  11. US 9403872

    Mutated anthrax toxin protective antigen proteins that specifically target cells containing high amounts of cell-surface metalloproteinases or plasminogen activator receptors

    The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted

  12. US 9404088

    Chitosan-based non-viral methods for transfecting gut cells in vivo

    ENGENE, INC. · Granted Aug 2, 2016 · Expires Jul 28, 2036

    granted

  13. US 9371516

    Compositions and methods for differentiating stem cells into cell populations comprising beta-like cells

    REGENERATIVE MEDICAL SOLUTIONS, INC. · Granted Jun 21, 2016 · Expires Jun 16, 2036

    granted

  14. US 9365823

    Virus clearance of neoplastic cells from mixed cellular compositions

    ONCOLYTICS BIOTECH INC. · Granted Jun 14, 2016 · Expires Jun 9, 2036

    granted

  15. US 2016159901

    DIAGNOSIS AND THERAPY OF CANCER INVOLVING CANCER STEM CELLS

    GANYMED PHARMACEUTICALS AG [DE] · Granted Jun 9, 2016 · Expires Jun 4, 2036

    granted

  16. US 9345726

    CD117+ cells and uses thereof

    The Regents of the University of Colorado, a Body Corporate · Granted May 24, 2016 · Expires May 19, 2036

    granted

  17. US 9333248

    Methods and composition related to Th-1 dendritic cells

    The Board of Regents of the University of Texas System · Granted May 10, 2016 · Expires May 5, 2036

    granted

  18. US 9327023

    HER2 targeting agent treatment in non-HER2-amplified cancers having HER2 expressing cancer stem cells

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted May 3, 2016 · Expires Apr 28, 2036

    granted

  19. US 9320774

    Method for reducing radio-resistance of prostate cancer cells and/or treating prostate cancer

    China Medical University · Granted Apr 26, 2016 · Expires Apr 21, 2036

    granted

  20. US 9314486

    Preparative regimen for engraftment, growth and differentiation of non-hematopoeitic cells in vivo after transplantation

    Montefiore Medical Center · Granted Apr 19, 2016 · Expires Apr 14, 2036

    granted

  21. US 9302015

    Anti-PRLR antibodies and methods for killing PRLR-expressing cells

    REGENERON PHARMACEUTICALS, INC. · Granted Apr 5, 2016 · Expires Mar 31, 2036

    granted

  22. US 9301976

    Compositions comprising perivascular stem cells and nell-1 protein

    The Regents of the University of California · Granted Apr 5, 2016 · Expires Mar 31, 2036

    granted

  23. US 9303080

    Codon optimized IL-15 and IL-15R-alpha genes for expression in mammalian cells

    The United States of America as Represented by The Secretary of the Department of Health and Human Services National Institutes of Health Office of Technology Transfer · Granted Apr 5, 2016 · Expires Mar 31, 2036

    granted

  24. US 9273284

    Method for generating potent dendritic cells

    The Regents of the University of California · Granted Mar 1, 2016 · Expires Feb 25, 2036

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.